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ABSTRACT
Background: Longitudinal growth associations with genetic vari-
ants identiﬁed for adult BMI may provide insights into the timing of
obesity susceptibility.
Objective: The objective was to explore associations of known
BMI loci with measures of body size from birth to adulthood.
Design: A total of 2537 individuals from a longitudinal British birth
cohort were genotyped for 11 genetic variants robustly associated
with adult BMI (in/near FTO, MC4R, TMEM18, GNPDA2,
KCTD15, NEGR1, BDNF, ETV5, SEC16B, SH2B1, and MTCH2).
We derived an obesity-risk-allele score, comprising the sum of
BMI-increasing alleles in each individual, and examined this for
an association with birth weight and repeated measures of weight,
height, and BMI SD scores (SDS) at 11 time points between ages 2
and 53 y.
Results: The obesity-risk-allele score showed borderline signiﬁcant
association with birth weight (0.019 SDS/allele; P = 0.05) and was
more clearly associated with higher weight and BMI at all time
points between ages 2 and 53 y; the strongest associations with
weight occurred at ages 11 and 20 y (both 0.056 SDS/allele). In
longitudinal analyses, the score was positively associated with
weight gain only between birth and 11 y (0.003 SDS/allele per year;
95% CI: 0.001, 0.004; P = 0.001). The risk-allele score was asso-
ciated with taller height at 7 y (0.031 SDS/allele; P = 0.002) and
greater height gains between 2 and 7 y (0.007 SDS/allele per year; P
, 0.001), but not with adult height (P = 0.5).
Conclusions: The combined effect of adult obesity susceptibility
variants on weight gain was conﬁned to childhood. These variants
conferred a faster tempo of height growth that was evident before
the pubertal years. Am J Clin Nutr 2012;95:1150–6.
INTRODUCTION
Accumulation of body fat resulting in overweight and obesity
is a gradual process that usually occurs over many years (1). It is
likely that the tendency to gain weight excessively and its sig-
niﬁcance for later obesity risk is not constant throughout the life
span (2). Whereas the rising level of obesity in recent decades is
attributable to lifestyle and environmental changes, genetic
differences between individuals may explain why some people
gain more weight than others in the same obesogenic setting.
Evidence indicates that genetic inﬂuences on BMI vary with age;
BMI heritability estimates appear to become progressively
stronger during childhood (3) but decrease into adulthood (4). In
addition,heritabilityestimatesofBMIchangeappeartobehigher
in adolescence than in young adulthood (5).
Common genetic variants that are robustly associated with
adult BMI were recently described in or near to FTO, MC4R,
TMEM18, SH2B1, KCTD15, BDNF, MTCH2, NEGR1, SEC16B,
GNPDA2, and ETV5 (6–9). Several of these loci show larger
cross-sectional associations with standardized BMI in children
and adolescents than in adults (10). Smaller studies with rich
phenotype data are useful to further characterize the timing of
effects of these polymorphisms, although such studies are often
underpowered to replicate the small effects of individual single
nucleotide polymorphisms (SNPs)
4 detected in larger meta-
analyses of genome-wide association studies. Longitudinal as-
sociations between weight gain and the 2 BMI loci with the
largest effect sizes in adults, at FTO and MC4R, were previously
described and show that the effects of these loci on BMI in-
crease over childhood and decrease in adulthood (11, 12). We
previously described the association between a genetic pre-
disposition score of adult BMI-increasing alleles across 8 loci
and increased childhood weight gain in the contemporary Avon
Longitudinal Study of Parents and Children (ALSPAC) population
(13). Such multiple allele scores increase statistical power and also
may be taken to represent a more generalizable inﬂuence of genetic
obesity susceptibility compared with analyses of individual
variants. However, because measures of adult body size were yet
unavailable in ALSPAC, it was unclear whether this obesity-risk-
allele score conferred susceptibility to additional weight gain
beyond the age of 11 y.
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changes in weight from birth into adulthood, longitudinal as-
sociations between a multiple risk-allele score for adult BMI
and measures of growth were tested in the Medical Research
Council National Survey of Health and Development (MRC
NSHD), also known as the 1946 British Birth Cohort Study. The
aim was to identify the periods of life during which individuals
with a greater genetic susceptibility to obesity show greater gains
in weight and BMI than those with lower genetic susceptibility.
Knowledge of these patterns of growth and weight gain could
help to inform the mechanisms of action of the genetic sus-
ceptibility to obesity.
SUBJECTS AND METHODS
Study sample
The NSHD is a socially stratiﬁed birth cohort of 2547 men and
2815 women of white European descent born during one week in
March 1946 who have been followed with repeated data col-
lections since then (14). At age 53 y, 1472 men and 1563 women
either were interviewed and examined in their own home by
trained research nurses (n = 2989) or completed postal ques-
tionnaires (n = 46). Contact was not attempted for 1510 in-
dividuals who had previously refused to take part, were living
abroad, or were untraced since the last contact at 43 y. A total of
469 individuals had already died. The remaining individuals
who were interviewed at 53 y were on the whole representative
of the native born population of that age (15). Blood samples for
DNA extraction were collected at the 53-y measurement from
2756 members. The study received Multi-Centre Research
Ethics Committee approval, and informed consent was given by
cohort participants.
Anthropometric measures
Birth weight to the nearest 0.25 lb (113 g) was extracted from
medical records and convertedto kilograms. Heights and weights
were measured by using standard protocols at ages 2, 4, 6, 7, 11,
15, 36, 43, and 53 y and self reported at ages 20 and 26 y.
Mothers’ weight and height were measured where possible, or
sometimes self-reported, when study members were 6 y of age.
Genotyping information
DNAwasextractedandpuriﬁed fromwholebloodbyusing the
Puregene DNA isolation Kit (Flowgen) according to the man-
ufacturer’s protocol. rs1421085 in FTO and rs17782313 near
MC4R were genotyped by Source Bioscience PLC with the
use of Applied Biosystems SNPlex technology (Foster Cirt),
which is based on an Oligonucleotide Ligation Assay combined
with multiplex PCR ampliﬁcation and capillary electrophoresis.
rs6548238 (TMEM18), rs8055138 (SH2B1), rs11084753 (KCTD15),
rs10838738 (MTCH2), rs2815752 (NEGR1), rs925946 (BDNF), and
rs10913469 (SEC16B) were typed by using the Sequenom iPLEX
platform (Sequenom), and rs10938397 (GNPDA2) and rs7647305
(ETV5) were genotyped by using custom TaqMan SNP geno-
typing assays according to the manufacturer’s protocol (Applied
Biosystems). Call rates for all SNPs were .95%, and allelic
distributions were in Hardy-Weinberg equilibrium (P . 0.05) (see
Supplementary Table 1 under “Supplemental data” in the online
issue).
Statistical methods
BMI at each measurement and maternal BMI were calculated
as weight (in kg) divided by height (in m) squared. Measures of
BMI, weight, and height were converted into SD scores (SDS) by
using internally generated growth charts, which arepreferable for
historical cohorts and were constructed by using the LMS (L =
skewness; M = median; S = coefﬁcient) method (16).
Missing genotypes were imputed in individuals who had
successful genotype calls at 7 of the 11 loci by assigning the
mean number of BMI-increasing alleles at each locus from in-
dividuals with successfully called genotypes. This ensured that
individuals who were missing genotypes at only a small number
of the variants were not excluded from the risk score analyses,
thereby maximizing the statistical power to detect associations.
The obesity-risk-allele score was then derived by summing the
number of genotyped or imputed BMI-increasing alleles across
the 11 loci in each individual. Differences in body size, level of
education, and maternal characteristics between included and
excluded individuals based on availability of the obesity-risk-
allele score were tested by using chi-square and t tests.
In initial cross-sectional analyses, the risk-allele score was
tested for linear association with birth weight as well as BMI,
weight, and height SDS at each time point between the ages of 2
and 53 y, with adjustment for sex, and additional adjustment for
the precise age at measurement in childhood when available (at
the 4-, 6-, 7-, 11-, and 15-y visits). The association analyses for
birth weight were also adjusted for mother’s BMI to remove any
potential confounding by intrauterine effects related to mother’s
genotype.Score-by-sexinteractiontermswerenotsigniﬁcantand
therefore all associations were examined in men and women
combined.
Multilevel modeling was used to test the association between
the risk-allele score and changes in weight, BMI, and height SDS
with age by using xtmixed in Stata. This approach takes corre-
lations between repeated measures on the same individual into
account and allows for missing measurement data assuming that
data are missing at random. We initially tested the association of
the risk-allele score with linear change in weight SDS between
birth and 53 y, BMI between 2 and 53 y, and height between 2 and
20 y (when ﬁnal adult height was assumed to be attained). Next,
we tested quadratic and cubic models by sequentially adding age
2
and age
3 and the interaction terms risk-allele-score · age
2 and
risk-allele-score · age
3. The signiﬁcance of each additional term
was tested by using Wald test statistics. Predicted models for
trajectories of BMI and weight SDS by tertile of obesity-risk-
allele score were plotted in Stata based on models that considered
a quadratic inﬂuence of age, because the cubic models were not
signiﬁcant. Because the effect of the risk-allele score on body size
varied with age, for ease of interpretation of longitudinal models
we stratiﬁed the data set to generate linear b coefﬁcients from
multilevel models that represent the effects of the risk-allele score
on gains in weight, height, and BMI in separate age periods.
Growth periods were divided according to the timing of the ob-
served peak in effect size in cross-sectional analyses; we modeled
periods from birth (2 y for BMI) to 11 y and from 11 to 53 y for
weight and BMI SDS and from 2 to 7 y and from 7 to 20 y for
height SDS.
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by the variants in FTO and MC4R, which tend to have the largest
effect sizes on adult BMI and were described previously in the
NSHD population (11), additional association analyses were
performed by using a 9-SNP obesity-risk-allele-score excluding
these 2 loci. Second, to allow comparison with the effect sizes
on childhood growth reported in the ALSPAC study (13), we
repeated the analyses using the same 8-SNP risk-allele score
used in that study, which excluded the SH2B1 and MTCH2
variants that had shown no individual association with childhood
BMI (10), as well as the SEC16B variant, which was not
available in ALSPAC. All analyses were performed by using
Stata version 11.0.
RESULTS
The NSHD population
A total of 2117 members of NSHD were successfully geno-
typed across all 11 BMI loci, whereas a further 420 had genotype
data on 7 variants. The imputed obesity-risk-allele score was
therefore derived in 2537 participants (1272 men and 1265
women) and was normally distributed, with all individuals car-
rying between 4 and 17 alleles out of the possible range of 0 to
22 alleles (see Supplementary Figure 1 under “Supplemental
data” in the online issue). Details of these 2537 participants are
shown in Table 1. Compared with NSHD members who were
excluded because of missing DNA or genotype data on .4 loci,
those included in the current analysis tended to have higher
educational qualiﬁcations, were slightly taller from age 7 y
onward, and had a slightly lower BMI at age 53 y (P , 0.05; see
Supplementary Table 2 under “Supplemental data” in the online
issue).
Cross-sectional associations
Weight
The obesity-risk-allele score showed a nominal positive as-
sociation with birth weight (0.019 SDS/allele; 95% CI: 0.00,
0.04; P = 0.05) and showed more clearly positive cross-sectional
associations with all repeated measures of weight SDS between
2 and 53 y (all P  0.03; Figure 1A; see Supplementary Table 3
under “Supplemental data” in the online issue). The largest ef-
fect sizes were seen at ages 11 y (0.056 SDS/allele; 95% CI:
0.036, 0.076; P = 6.25 · 10
28) and 20 y (0.056 SDS/allele; 95%
CI: 0.036, 0.076; P = 2.58 · 10
28). At age 11 y, the risk-allele
score explained 1.6% of the variance in weight SDS.
BMI
A similar pattern was observed for associations with BMI
SDS, which also peaked at ages 11 y (0.063 SDS/allele; 95% CI:
0.043, 0.083; P = 1.06 · 10
29) and 20 y (0.066 SDS/allele; 95%
CI: 0.046, 0.086; P = 8.58 · 10
211) (Figure 1B; see Supple-
mentary Table 3 under “Supplemental data” in the online issue).
Height
The risk-allele score was positively associated with height
SDS at 7 y (0.031 SDS/allele; 95% CI: 0.011, 0.051; P = 0.007)
(Figure 1C; see Supplementary Table 3 under “Supplemental
data” in the online issue) but showed no association with adult
height (at age 36 y: 0.006 SDS/allele; 95% CI: 20.012, 0.025;
P = 0.5).
Comparison of extremes of the obesity-risk-allele score
Individuals with 14 obesity risk alleles (n = 189) were, on
average, 1.56 kg/m
2 and 3.58 kg heavier at age 11 y and 1.6 cm
taller at 7 y than were those with 7 alleles (n = 161).
Longitudinal associations
The associations between the risk-allele score and BMI,
weight, and height SDS appeared to vary with age in a nonlinear
manner (Figure 1, A, B, and C). This was conﬁrmed in quadratic
multilevel models in which the interaction term risk-allele-score
· age
2 was highly signiﬁcant for BMI and weight SDS to age
53 y (both P , 0.001). Cubic age and risk-allele score · age
3
TABLE 1
Summary of growth data by age and sex in 2537 individuals from the
National Survey of Health and Development
1
Men Women
No. of
observations Mean SD
No. of
observations Mean SD
Weight (kg)
Birth 1268 3.5 0.5 1262 3.3 0.5
2 y 1068 13.2 1.5 1039 12.7 1.5
4 y 1149 17.5 2.1 1133 17.1 2.1
6 y 1082 20.8 2.6 1064 20.4 2.6
7 y 1063 23.0 3.0 1056 22.6 3.1
11 y 1079 34.3 6.0 1054 35.2 6.8
15 y 1005 51.8 9.4 966 52.1 8.1
20 y 1015 70.6 9.1 1041 57.9 8.3
26 y 1091 73.3 10.1 1102 59.2 8.8
36 y 1140 76.0 11.0 1157 62.2 10.5
43 y 1179 78.7 11.7 1199 66.3 12.3
53 y 1263 83.4 13.1 1255 71.6 13.9
BMI (kg/m
2)
2 y 1014 18.0 2.6 964 17.6 2.4
4 y 1103 16.3 1.6 1079 16.1 1.6
6 y 1036 15.9 1.3 1015 15.7 1.4
7 y 1059 15.9 1.4 1050 15.7 1.5
11 y 1069 17.3 2.2 1051 17.5 2.5
15 y 990 19.6 2.5 956 20.6 2.8
20 y 996 22.6 2.4 1026 21.9 2.9
26 y 1091 23.4 2.8 1102 22.4 3.1
36 y 1136 24.7 3.2 1154 23.5 3.8
43 y 1179 25.6 3.4 1191 25.1 4.6
53 y 1263 27.3 3.9 1252 27.4 5.3
Height (cm)
2 y 1054 85.8 5.2 1008 84.8 4.5
4 y 1121 103.4 5.0 1107 103.0 5.0
6 y 1084 114.4 5.2 1059 113.9 5.3
7 y 1101 120.4 5.7 1096 119.9 5.5
11 y 1085 140.6 6.7 1063 141.4 6.9
15 y 1002 162.1 8.9 968 158.9 6.2
20 y 1018 177.0 6.7 1039 162.7 6.1
26 y 1092 177.0 6.5 1104 162.6 6.3
36 y 1139 175.3 6.5 1158 162.6 5.8
43 y 1179 175.1 6.6 1194 162.6 6.0
53 y 1264 174.5 6.5 1260 161.8 5.9
1 Data are from individuals measured at the 53-y visit with complete or
imputed genotype information.
1152 ELKS ET ALterms were not signiﬁcant (both P . 0.14). Quadratic prediction
models for BMI and weight SDS by risk-allele-score tertiles
between birth and 53 y illustrate that growth trajectories diverge
during childhood and converge during later adult life according
to level of genetic predisposition (Figure 2, A and B). In mul-
tilevel models stratiﬁed by age period, the risk-allele score was
associated with greater weight gain between birth and 11 y
(0.003 SDS/allele per year; 95% CI: 0.001, 0.004; P = 0.001)
and greater gains in BMI between 2 and 11 y (0.005 SDS/allele
per year; 95% CI: 0.002, 0.007; P , 0.001) (Table 2). The risk-
allele score association with weight SDS subsequently declined
up to age 53 by 20.0003 SDS/allele per year (P = 0.02), and
a similar decline was seen in the association with BMI SDS by
20.0005 SDS/allele per year (P = 0.001).
ForheightSDS,inviewofadifferentpatternofcross-sectional
associations over time and the limited period for growth, we
divided the data into 2 periods, 2–7 and 7–20 y, which broadly
represented height growth before and after the onset of puberty
given the data available. The obesity-risk-allele score was as-
sociated with greater height growth between 2 and 7 y (0.007
SDS/allele per year; 95% CI: 0.003, 0.010; P , 0.001) and
subsequently with slower height growth (20.002 SDS/allele per
year; P = 0.007) between 7 and 20 y (Table 2).
Sensitivity analyses
When the FTO and MC4R variants were removed from the
risk allele-score, the cross-sectional associations between the
resulting 9-SNP risk-allele score and weight or BMI SDS be-
tween birth and 53 y were only slightly lower than the original
11-SNP score (see Supplementary Table 4 under “Supplemental
FIGURE 1. Associations between the obesity-risk-allele score and weight
SDS (A), BMI SDS (B), and length/height SDS (C) between birth and 53 y
in the National Survey of Health and Development. Regression coefﬁcients
(695% CIs) from linear regression models are shown [adjusted for sex,
precise age at measurement (up to the visit at age 15 y), and mother’s
BMI (for birth weight only)]. SDS, SD scores.
FIGURE 2. Predicted weight and BMI by tertiles of the obesity-risk-
allele score. From prediction models of weight (A) and BMI (B) SDS by
risk-allele-score tertiles with ﬁtted quadratic age interaction terms. The solid
line represents the mean SDS in those in the highest tertile of the risk-allele
score, the dashed line the middle tertile, and the dash-dot line the lowest
tertile. Shaded areas indicate 95% CIs. SDS, SD scores.
GROWTH PATTERNS AND OBESITY SUSCEPTIBILITY 1153data” in the online issue). Associations remained signiﬁcant
(P , 0.05) at all time points except age 4 y. As with the original
risk-allele score, this smaller 9-SNP risk-allele score showed
similar patterns of association with body size and weight gain,
with the strongest associations for BMI SDS at ages 11 and 20 y,
and a positive association with height at 7 y (P = 0.02) (see
Supplementary Table 3 under “Supplemental data” in the online
issue). Longitudinal associations of the risk-allele score per-
sisted with greater childhood gains in BMI and height SDS.
However, the 9-SNP risk-allele-score associations with adult-
hood weight and BMI SDS did not show signiﬁcant attenuation
with increasing age (P . 0.2). Further sensitivity analyses using
the same 8-SNP risk-allele score as that used in the ALSPAC
study (13) resulted in slightly larger per-allele effect sizes
compared with the 11-SNP score. For example, the association
of the 8-SNP risk-allele score with BMI SDS at weight gain
between birth and 11 y was 0.004 SDS/allele per year (95% CI:
0.003, 0.006). This remains slightly lower than the effect size of
this 8-SNP risk-allele score on weight gain during the same age
period in the more contemporary ALSPAC study (0.005 SDS/
allele per year; 95% CI: 0.004, 0.006).
DISCUSSION
The results from this study show that genetic variants that
predispose to higher adult BMI are in combination associated
with greater gains in weight up to age 11 y and with gains in
height up to age 7 y. After age 11y, individuals with more obesity
risk alleles remain heavier but do not continue to gain weight
morerapidly during adulthood than do thosewhocarry fewer risk
alleles. In contrast with the associations with weight, the positive
association between these obesity susceptibility variants and
childhood height did not persist into adulthood. This pattern of
faster early childhood gains in height followed by subsequent
slower height growth and unchanged adult height indicates that
obesity risk alleles may confer a more rapid tempo of growth
rather than altered long-term height potential.
Associations between a faster tempo of childhood growth and
adult obesity risk have been described previously in nongenetic
studies. In the 1958 British Birth cohort, individuals who achieved
a greater proportion of their adult height by age 7 y had an
increased risk of obesity at age 33 y (17). Similarly, a US study
recently reported that overweight or obese adults were taller as
children but had relatively less growth during their teenage years
(18). Notably, the acceleration in childhood height becomes ap-
parent before the age of pubertal onset and so it is not simply
a marker of an earlier pubertal growth spurt. Our observed as-
sociation between the obesity-risk-allele score and height SDS
suggests that being taller at age 7 y relative to one’s adult height
potential may indicate genetic susceptibility to a rapid growth
trajectorythatisassociatedwithlaterobesityrisk.Thisprepubertal
indicatormayoccuratanageatwhichchildrenaremoreconducive
to interventions to prevent excessive weight gain than during
adolescence.The challengeistoaccurately andsafelydifferentiate
thesetalleryoungchildren,whowillexperienceearliercessationof
growth because of earlier maturation from those on a healthy
trajectory to becoming taller adults.
This NSHD cohort is unique in being able to analyze longi-
tudinal data on weight and BMI over such a long period. The
positive inﬂuence of adult obesity susceptibility variants on
weightgainwasattained largelyinchildhood,whichisconsistent
with previous cross-sectional ﬁndings showing that these loci
have similar effect sizes on BMI SDS in children and adults (10).
Furthermore, the difference in childhood BMI of ;0.5 SDS
between the highest and lowest groups of the obesity-risk-allele
score in the NSHD is similar to that observed in other adult
populations (13). This provides further evidence that greater
gains in weight associated with these loci are already achieved
in childhood and is further supported by recent ﬁndings of
a large-scale adult study showing that the BMI-increasing allele
at the FTO locus does not confer greater weight gain in adult-
hood (19).
Whereas combining established genetic variants for BMI into
a risk-allele score maximized statistical power, this approach
masks possible heterogeneity in effects of individual variants.
The FTO and MC4R loci were the ﬁrst to be identiﬁed by ge-
nome-wide association studies for adult BMI as these variants
are common and have the largest effect sizes (6, 7). We pre-
viously described in the NSHD cohort that the FTO and MC4R
variants showed comparable associations with BMI and weight,
with a biphasic pattern over the life course; the associations with
both loci strengthened during childhood and adolescence,
peaked at age 20 y, and weakened into adulthood (11). Sensi-
tivity analyses were therefore performed excluding these loci,
TABLE 2
Longitudinal multilevel modeling of the associations between the risk-allele score with changes in weight, BMI, and
height SDS
1
N Effect size per risk allele per year
2 95% CI P
3
Change in weight SDS
0–11 y 2537 0.0027 (0.0011, 0.0042) 0.001
11–53 y 2537 20.0003 (20.0006, 0.0000) 0.023
Change in BMI SDS
2–11 y 2465 0.0049 (0.0024, 0.0074) ,0.001
11–53 y 2537 20.0005 (20.0009, 20.0002) 0.001
Change in height SDS
2–7 y 2461 0.0065 (0.0029, 0.0100) ,0.001
7–20 y 2414 20.0014 (20.0024, 0.0004) 0.008
1 SDS, SD scores.
2 Regression coefﬁcients from the interaction term “risk-allele score · age” represent the association between risk-
allele score and changes in weight, BMI, or height SDS per risk allele per year.
3 Statistical tests were performed by using multilevel modeling.
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SDS was also seen with the remaining 9 SNPs in combination,
which suggested that this timing of association may be generic
across multiple BMI loci. The current study is underpowered to
distinguish between individual genotype associations on patterns
of growth over the life course, and larger cross-study approaches
would be required for this. Information on the association of
individual SNPs with childhood weight gain to inform such
future efforts is shown elsewhere (see Supplementary Table 5
under “Supplemental data” in the online issue).
The NSHD has been shown to be broadly representative of the
nonmigrant British population of a similar age (15). Their mean
BMI values at age 53 y (Table 1) were in the middle of the
overweight range (BMI: 25–30), which is consistent with other
studies of this age group. It is important to recognize that it is not
possible to disentangle age and period effects in the NSHD,
because all study members were born within the same week in
1946. NSHD members experienced postwar food rationing from
birth to age 8 y, and the prevalence of childhood obesity was very
low, which could lead to different penetrance of the inﬂuence of
these genetic variants on weight gain compared with populations
with unrestricted caloriﬁc intake (20). It is possible that stan-
dardization of diet achieved by food rationing could contribute to
stronger observed genetic inﬂuences on childhood versus later
weight gain. Comparison between different birth cohorts mea-
sured across thesame timeperiods is necessary to clarify whether
life-course differences in weight gain associated with obesity-
susceptibilitylociaretrulyduetoageorwhethertheymayalsobe
modiﬁed by environmental changes over time.
The per-allele effect size of an identical risk-allele score on
rate of weight gain between birth and 11 y was slightly lower in
the NSHD (0.003 SDS/allele per year) than that reported in the
ALSPAC population—a cohort born in 1991–1992 (0.005 SDS/
allele per year) (13). In ALSPAC, a signiﬁcant association of the
risk-allele score with length was observed as early as age 6 wk
and persisted throughout childhood. Whereas the NSHD does not
have data on infant length before the age of 2 y, a trend toward
increased height attributable to BMI-increasing alleles was not
observed until much later, at 6 y of age. It is possible that these
differences could reﬂect an increase in the penetrance of genetic
obesity susceptibility from the 1940s to the 1990s. This in-
terpretation is consistent with ﬁndings from a multigenerational
study,which demonstrated that loss-of-function MC4R mutations
had higher penetrance in younger generations (21). It is possible
that “obesogenic” conditions allow genetic susceptibility to
greater adiposity and weight gain to become more visible.
Another limitation of this study was that the variants used in
the risk-allele score explained only a small fraction of the var-
iance and heritability of BMI. A recent expanded genome-wide
association study yielded further loci associated with adult BMI
(22); addition of these variants will permit more powerful lon-
gitudinal analyses of the growth patterns associated with obesity
susceptibility.Agreaterunderstandingoftheroleoftheseobesity
risk alleles will provide a more complete picture of the mech-
anisms of obesity susceptibility. Whereas this study provides
insightsintothetimingofweightchangesassociated withgenetic
obesity risk, it does not explain the molecular or physiologic
processes that bring about these changes. Given that the effects of
these variants on weight gain are only apparent in childhood, it is
likely that the actions of these genes may become less important
with age; therefore, we suggest that future mechanistic studies
should include these key age periods.
We found a borderline signiﬁcant association between the
obesity-risk-allele score and increased birth weight. A recent
large meta-analysis of 24,274 individuals found no association
betweenasimilarcompositeobesitysusceptibilityscoreandbirth
weight (23). Although that study largely relied on studies of self-
reported birth weight data, other studies with more accurate birth
weight records also found no associations with obesity suscep-
tibility risk scores (13, 24). Maternal genotype may confound the
association between fetal genotype and birth weight, because
mother-offspring genotypes are correlated and birth weight is
inﬂuenced by the in utero environment. However, in this study,
theassociationremainedevenafteradjustmentformother’sBMI,
and there is no clear explanation for these contrasting ﬁndings.
In conclusion, the combined inﬂuence of adult obesity-
susceptibility variants on faster rates of weight gain appears to be
conﬁned to the ﬁrst 11 y of life rather than continuing into later
adolescence and adulthood. However, differences in BMIs be-
tween groups with higher or lower obesity-risk-allele scores
continue to track throughout adult life, which suggests an active
persistence of their effects on energy homeostasis. This persis-
tence might be modiﬁable by adult life environmental factors
(25). Finally, the association between genetic obesity-risk-allele
scores and a faster tempo of height growth suggests that this
growth trajectory may contribute to the identiﬁcation of young
children with high long-term obesity susceptibility.
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